TPG (NASDAQ:TPG – Get Free Report) released its quarterly earnings results on Monday. The company reported $0.45 earnings per share for the quarter, meeting the consensus estimate of $0.45, Briefing.com reports. The business had revenue of $855.40 million for the quarter, compared to analysts’ expectations of $449.98 million. TPG had a net margin of 0.69% and a return on equity of 23.57%. During the same quarter in the previous year, the business posted $0.56 earnings per share.
TPG Stock Performance
Shares of TPG stock opened at $60.88 on Wednesday. The stock has a market cap of $22.21 billion, a price-to-earnings ratio of -179.05, a PEG ratio of 0.98 and a beta of 1.49. The firm’s 50-day moving average is $58.95 and its 200 day moving average is $49.39. TPG has a 1 year low of $28.93 and a 1 year high of $69.86. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.25 and a quick ratio of 0.25.
TPG Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Thursday, November 14th will be paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Thursday, November 14th. TPG’s payout ratio is -494.10%.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on TPG
TPG Company Profile
TPG Inc operates as an alternative asset manager in the United States and internationally. The company offers investment management services to TPG Funds, limited partners, and other vehicles. It also offers monitoring services to portfolio companies; advisory, debt and equity arrangement, and underwriting and placement services; and capital structuring and other advisory services to portfolio companies.
Further Reading
- Five stocks we like better than TPG
- Do ETFs Pay Dividends? What You Need to Know
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Retail Stocks Investing, Explained
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- How to Invest in Blue Chip Stocks
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for TPG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TPG and related companies with MarketBeat.com's FREE daily email newsletter.